企業プロフィール
Amylyx 株価・ニュース・カタリスト
- ティッカー:
- AMLX
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
21.43 USD (-0.92%)
終値
最終更新: 2026年8月17日
1.48B USD
時価総額
株価変動の要因
As of Aug 17, 2026, AMLX closed down 0.92% at $21.43. No new same-company headline was identified in the current news window.
企業概要
事業概要
Amylyx is a neuroscience company that has shifted after Relyvrio toward a broader rare-disease and neurodegeneration pipeline.
所在地とセクター分類
Headquartered in the United States and listed on NASDAQ, Amylyx sits in specialty neuroscience biotech.
ビジネスモデルの特徴
The company now depends on pipeline execution, data credibility, and rebuilding investor confidence after a major product reset.
バイオ業界での位置付け
Amylyx remains a headline-sensitive CNS name because the market is still reassessing its long-term story.
今後のカタリスト
- Amylyx's catalysts are AMX0114 and the post-Relyvrio pipeline reset, which need to show the company still has a credible neuroscience path. The next update matters because the story is still being rebuilt.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。